Company news
Ironwood Pharmaceuticals, Inc. news in 2025
Ironwood Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
November 9, 2025
EchoStor Technologies Bolsters C-Suite with Appointment of Cale Anjoorian as Chief Information Officer
August 25, 2025
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
August 6, 2025
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
May 6, 2025
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
April 29, 2025
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
April 24, 2025
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
April 21, 2025
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
April 13, 2025
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
March 26, 2025
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
February 26, 2025
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
February 19, 2025
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
January 28, 2025
Calls in 2025
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 14 slides · Nov 10, 2025
- FY2024 Earnings Presentation
Earnings · 19 slides · Feb 27, 2025